mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |